GleamWall
中文EN

MRM Medirom Healthcare Technologies Inc. Annual reports only

Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—

Margins

Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%

Returns

ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x

Cash quality & payout

Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: JPY FY20252025-12-31FY20242024-12-31
Income statement
Revenue6.23B8.30B
Cost of revenue—6.05B
Gross profit—2.25B
SG&A expense2.57B2.24B
Operating income-3.39B-18.10M
Interest expense66.19M49.74M
Pretax income-3.34B47.71M
Income tax304.12M-90.48M
Net income-3.63B148.76M
EBITDA-2.86B271.94M
EPS (basic)-459.9229.13
EPS (diluted)-459.9228.52
Weighted avg. shares (diluted)7.90M5.85M
Balance sheet
Cash & equivalents91.98M329.40M
Short-term investments6.16M6.16M
Receivables671.66M1.36B
Inventory156.62M151.64M
Current assets1.49B2.71B
PP&E, net154.62M435.66M
Goodwill0389.13M
Intangibles862.65M1.14B
Total assets4.68B8.09B
Current liabilities4.73B4.18B
Short-term debt161.32M620.81M
Long-term debt799.96M764.20M
Total debt961.28M1.39B
Total liabilities7.11B6.90B
Shareholders' equity-2.67B933.27M
Net debt869.30M1.06B
Shares outstanding7.90M2,024
Cash flow statement
Operating cash flow-1.16B-1.33B
Capital expenditure10.30M71.41M
Free cash flow-1.17B-1.40B
Investing cash flow-22.46M361.39M
Financing cash flow940.04M1.19B
Depreciation & amortization532.66M290.04M
Stock-based compensation0—

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.